Filter By Industry
Filter By Tag

Newsroom

Corporate Ads Press releases

21 - 30 of 292 Press Releases

$20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
Jun 25, 2026
Strategic Business Transformation, Enterprise Healthcare Expansion, AI-Powered Telehealth Innovation, And Significant Cost Reductions Position $VSEE Health For Potential Multi-Year Growth

Advancing High-Potential Nevada Critical Minerals Portfolio as Major Drill Program Nears Assay Results: Glenstar Minerals: Stock Symbol: GSTRF
Jun 15, 2026
Glenstar Minerals Inc. (O T C Q B: GSTRF) (C S E: GSTR) $GSTRF Wildhorse Project Delivers Encouraging Gold, Copper, Silver, Antimony, Tungsten and Bismuth Indicators While 860 Drill Samples Await Laboratory Results

$150+ Million Contracted Backlog, Strategic Acquisitions Adding Millions In Recurring Revenue, Improving Margins & A Clear Path Toward Profitability
Jun 10, 2026
Cycurion, Inc. (N A S D A Q: CYCU): Acquisitions of Halo Privacy, HavenX, Secuvant, plus Expanding Government Contracts, Strong Revenue Visibility, And Significant Operating Improvements Position Cycurion For Potential Multi-Year Growth

Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
Jun 10, 2026
Cosmos Health Inc. (N A S D A Q: COSM): 18 Series Nutraceutical Expansion, Record Q1 Results, EIB Financing Initiative, AI-Powered Drug Development, And Strong Long-Term Financial Guidance Position Cosmos Health For Potential Multi-Year Expansion

Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
Jun 03, 2026
$GRML has Secured One of the Most Strategically Located Rare Earth Projects in the Western World Through a $35 Million Agreement with Neo Performance Materials.

Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
Jun 03, 2026
Cosmos Health Inc. (N A S D A Q: COSM): Veterinary Expansion, Proprietary Healthcare Brands, AI-Powered Drug Development, Telehealth Growth, and Strong Financial Guidance Position Cosmos Health for Potential Multi-Year Expansion

$97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
Jun 03, 2026
$IQST Delivering Nearly 70% Growth and Gross profit increased 7.8% to $2.08 million

FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
May 28, 2026
Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth

Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
May 27, 2026
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase

Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
May 20, 2026
$CDIX Continues Scaling Its Orthopedic, Spine, and Pain Management Footprint as Revenue Growth, Margin Expansion, and Capital Markets Momentum Accelerate


Page: Prev 1 2 3 4 5 Next
Corporate Ads RSS Feed